Enzyme-Inspired Method Places Two Stereocentres Side by Side

Shanghai Jiao Tong University Journal Center

A study published in Transformative Chemistry by Xingdie Yang, Pengwei Ji, Liang Liu, Tongyin Chen, Siqi Liu, Wen-Wen Chen and Baoguo Zhao from Shanghai Normal University and Shanghai Jiao Tong University reports a modular one-pot, two-step route that turns unprotected aminoacetonitrile directly into α-quaternary cyanopyrrolines bearing two contiguous stereocentres. A chiral pyridoxal catalyst performs the asymmetric α-conjugate addition of aminoacetonitrile to α,β-unsaturated ketones with the free NH2 group, and the resulting enantioenriched adduct is then trapped with a second electrophile in the same flask, giving up to 99% yield, >20:1 dr and 98% ee.

Why This Research Matters

· Two contiguous stereocentres, one of them quaternary: Building adjacent stereocentres that include a quaternary carbon is one of the harder problems in organic synthesis. The sequence assembles them in two operations from cheap, readily available starting materials, and the nitrile of the cyanopyrroline products is a convenient handle for further conversion.

· No protecting group on the amine: Aminoacetonitrile is used with its NH2 group free, because the pyridoxal catalyst turns it into a nucleophilic carbanion equivalent through carbonyl catalysis. The usual detour of protecting, pre-functionalising and deprotecting the amine disappears, which matters because the corresponding α-substituted aminoacetonitriles are not even commercially available and must be made in several steps.

· Vitamin B6 chemistry put to work: The chiral pyridoxal reproduces the reactivity of vitamin B6-dependent enzymes, and this work reports the first direct α-C conjugate addition of aminoacetonitrile to enones, extending biomimetic asymmetric catalysis to a new bond construction.

Innovative Design and Mechanisms

· Two organocatalytic cycles running side by side: Pyridoxal (R)-4a condenses with aminoacetonitrile and coordinates ZnCl2 to give an imine–Zn complex (10), which is deprotonated to a resonance-stabilised carbanion (11). In parallel, pyrrolidine (12) converts the enone into an iminium ion (13, observed by HRMS). Addition of 11 to 13, hydrolysis and spontaneous cyclisation deliver the cyanopyrroline 3a. Both ZnCl2 and water are required for high enantioselectivity, in line with a transition-state model in which Zn2+ and H2O lock the reactive conformation while the amide side chain of (R)-4a shields one face of the iminium ion.

· A chirality relay that outruns epimerisation: The α-C–H of 3a epimerises readily under basic conditions and 3a itself is obtained with only about 4:1 dr, with trans and cis 3a interconverting without loss of ee. Even so, the second C–C bond-forming step, run under achiral conditions, delivers 6a with >20:1 dr and 98% ee: the stereocentre installed in the first step dictates the face attacked in the second, so the relay preserves the quaternary stereochemical integrity of the product.

· Configuration and modularity proven: X-ray analysis of 6p establishes the (2R,3R) configuration, and the side-chain stereocentre of 6ag is (S), set by the incoming electrophile. Trying to reach 6a directly from a pre-formed α-benzyl aminoacetonitrile gives only traces, which shows why the quaternary centre is best built by sequential addition rather than by pre-functionalising the nucleophile.

Applications and Future Outlook

Aryl, naphthyl, heteroaryl, alkenyl and alkynyl enones are all accepted (62–99% yield, 90–98% ee), and the second electrophile can be an allyl or propargyl bromide, an enone, a vinyl phosphonate, a vinyl sulfone, acrylonitrile, an acrylate or an acrylamide. Late-stage modification succeeds on derivatives of (–)-isopulegol, icaridin, pregnenolone, paroxetine and oestradiol, with yields up to 99% and dr up to >99:1. The sequence also runs on gram scale (85% yield, >20:1 dr, 98% ee), and the products are converted into amines, amides and a chiral spiro lactam without erosion of stereochemistry, which the authors present as a general platform for bioactive α-quaternary pyrrolines.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.